DoseDenseTherapyPhyllodesTumorPARPInhibitorsChemopreventionWomen ages20-39 yoshould have aclinical breastexam at leastevery 3 years.MultimodalityTherapyWomen ages40+ shouldhave a clinicalbreast examat least yearlyBRCAGeneBOCABreastCancerIn-situCarcinomaGermlineMutationMorpheaFISHAlopeciaGailModelGeneticPredispositionEstimated 2,150 menwill be diagnosedwith breast cancerand approximately410 will die each yearNeoadjuvantTherapyRadiotherapyAdenocarcinomaDown-StagingMastodyniaCMFChemotherapyRelapseRaloxifeneAdvocacyTumorGradePagetDiseaseLumpectomyEstrogen/EstradiolBiopsyKappaEpsilonDoxorubicinMastectomyTamoxifenEGFRHER-2ER+/-LCISAbsoluteRiskCAMGuaranteedRenewableInsuranceAromataseInhibitorsDefinitiveSurgeryLumpAntiemeticsImmunotherapyHormoneReplacementTherapyMammography is alow-dose X-rayexamination thatcan detect breastcancer two yearsbefore it is largeenough to be feltMethotrexatePathologicResponseTyrosine-KinaseInhibitorTriple +/-BreastCancerDocetaxelDimplingPI3KinaseInhibitorsCalcificationsECOGScoreAlcohol intakeof more thantwo drinks perday is a riskfactor for breastcancerCachexiaLymphoscintigraphyOvarianSuppressionHormoneReceptorStatusAfrican-Americanwomen have a lowerchance of breastcancer overall, butthey are 40% morelikely to die frombreast cancer thanwhite women1 in 8womenCDK4/6InhibitorsMRIAnastrozolePhysicalactivity mayreduce therisk of breastcancersFibroadenomaBrachytherapyGeneMutationChemotherapyPalpationBevacizumabBreastTomosynthesisGeneticCounselingIntraductalPapillomaStagingFamilyHistoryCytotoxicRADFor every 1,000screeningmammogramsperformed, aboutfive breast cancersare detected.PalbociclibAyurvedaMegestrolAcetateLymphNodeStatusSelf-examinationLapatinibMetastasisBI-RADSHerceptinAngiogenesisCystPrecisionMedicineBilateralProphylacticMastectomyOligometastases5-FluorouracilSERMMultifocalTumorsAntibodyTherapyProgestinAdjuvantTherapyCytostaticBreast cancer isthe leading causeof death in womenbetween the agesof 40 and 55PaclitaxelCo-survivorCyclophosphamideKi-67RateACChemotherapyCapecitabineCheckpointInhibitormTORInhibitorsFlowCytometryApoptosisDoseDenseTherapyPhyllodesTumorPARPInhibitorsChemopreventionWomen ages20-39 yoshould have aclinical breastexam at leastevery 3 years.MultimodalityTherapyWomen ages40+ shouldhave a clinicalbreast examat least yearlyBRCAGeneBOCABreastCancerIn-situCarcinomaGermlineMutationMorpheaFISHAlopeciaGailModelGeneticPredispositionEstimated 2,150 menwill be diagnosedwith breast cancerand approximately410 will die each yearNeoadjuvantTherapyRadiotherapyAdenocarcinomaDown-StagingMastodyniaCMFChemotherapyRelapseRaloxifeneAdvocacyTumorGradePagetDiseaseLumpectomyEstrogen/EstradiolBiopsyKappaEpsilonDoxorubicinMastectomyTamoxifenEGFRHER-2ER+/-LCISAbsoluteRiskCAMGuaranteedRenewableInsuranceAromataseInhibitorsDefinitiveSurgeryLumpAntiemeticsImmunotherapyHormoneReplacementTherapyMammography is alow-dose X-rayexamination thatcan detect breastcancer two yearsbefore it is largeenough to be feltMethotrexatePathologicResponseTyrosine-KinaseInhibitorTriple +/-BreastCancerDocetaxelDimplingPI3KinaseInhibitorsCalcificationsECOGScoreAlcohol intakeof more thantwo drinks perday is a riskfactor for breastcancerCachexiaLymphoscintigraphyOvarianSuppressionHormoneReceptorStatusAfrican-Americanwomen have a lowerchance of breastcancer overall, butthey are 40% morelikely to die frombreast cancer thanwhite women1 in 8womenCDK4/6InhibitorsMRIAnastrozolePhysicalactivity mayreduce therisk of breastcancersFibroadenomaBrachytherapyGeneMutationChemotherapyPalpationBevacizumabBreastTomosynthesisGeneticCounselingIntraductalPapillomaStagingFamilyHistoryCytotoxicRADFor every 1,000screeningmammogramsperformed, aboutfive breast cancersare detected.PalbociclibAyurvedaMegestrolAcetateLymphNodeStatusSelf-examinationLapatinibMetastasisBI-RADSHerceptinAngiogenesisCystPrecisionMedicineBilateralProphylacticMastectomyOligometastases5-FluorouracilSERMMultifocalTumorsAntibodyTherapyProgestinAdjuvantTherapyCytostaticBreast cancer isthe leading causeof death in womenbetween the agesof 40 and 55PaclitaxelCo-survivorCyclophosphamideKi-67RateACChemotherapyCapecitabineCheckpointInhibitormTORInhibitorsFlowCytometryApoptosis

BOCA Bingo - Call List

(Print) Use this randomly generated list as your call list when playing the game. There is no need to say the BINGO column name. Place some kind of mark (like an X, a checkmark, a dot, tally mark, etc) on each cell as you announce it, to keep track. You can also cut out each item, place them in a bag and pull words from the bag.


1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
  1. Dose Dense Therapy
  2. Phyllodes Tumor
  3. PARP Inhibitors
  4. Chemoprevention
  5. Women ages 20-39 yo should have a clinical breast exam at least every 3 years.
  6. Multimodality Therapy
  7. Women ages 40+ should have a clinical breast exam at least yearly
  8. BRCA Gene
  9. BOCA
  10. Breast Cancer
  11. In-situ Carcinoma
  12. Germline Mutation
  13. Morphea
  14. FISH
  15. Alopecia
  16. Gail Model
  17. Genetic Predisposition
  18. Estimated 2,150 men will be diagnosed with breast cancer and approximately 410 will die each year
  19. Neoadjuvant Therapy
  20. Radiotherapy
  21. Adenocarcinoma
  22. Down-Staging
  23. Mastodynia
  24. CMF Chemotherapy
  25. Relapse
  26. Raloxifene
  27. Advocacy
  28. Tumor Grade
  29. Paget Disease
  30. Lumpectomy
  31. Estrogen/Estradiol
  32. Biopsy
  33. Kappa Epsilon
  34. Doxorubicin
  35. Mastectomy
  36. Tamoxifen
  37. EGFR
  38. HER-2
  39. ER +/-
  40. LCIS
  41. Absolute Risk
  42. CAM
  43. Guaranteed Renewable Insurance
  44. Aromatase Inhibitors
  45. Definitive Surgery
  46. Lump
  47. Antiemetics
  48. Immunotherapy
  49. Hormone Replacement Therapy
  50. Mammography is a low-dose X-ray examination that can detect breast cancer two years before it is large enough to be felt
  51. Methotrexate
  52. Pathologic Response
  53. Tyrosine-Kinase Inhibitor
  54. Triple +/- Breast Cancer
  55. Docetaxel
  56. Dimpling
  57. PI3 Kinase Inhibitors
  58. Calcifications
  59. ECOG Score
  60. Alcohol intake of more than two drinks per day is a risk factor for breast cancer
  61. Cachexia
  62. Lymphoscintigraphy
  63. Ovarian Suppression
  64. Hormone Receptor Status
  65. African-American women have a lower chance of breast cancer overall, but they are 40% more likely to die from breast cancer than white women
  66. 1 in 8 women
  67. CDK4/6 Inhibitors
  68. MRI
  69. Anastrozole
  70. Physical activity may reduce the risk of breast cancers
  71. Fibroadenoma
  72. Brachytherapy
  73. Gene Mutation
  74. Chemotherapy
  75. Palpation
  76. Bevacizumab
  77. Breast Tomosynthesis
  78. Genetic Counseling
  79. Intraductal Papilloma
  80. Staging
  81. Family History
  82. Cytotoxic
  83. RAD
  84. For every 1,000 screening mammograms performed, about five breast cancers are detected.
  85. Palbociclib
  86. Ayurveda
  87. Megestrol Acetate
  88. Lymph Node Status
  89. Self-examination
  90. Lapatinib
  91. Metastasis
  92. BI-RADS
  93. Herceptin
  94. Angiogenesis
  95. Cyst
  96. Precision Medicine
  97. Bilateral Prophylactic Mastectomy
  98. Oligometastases
  99. 5-Fluorouracil
  100. SERM
  101. Multifocal Tumors
  102. Antibody Therapy
  103. Progestin
  104. Adjuvant Therapy
  105. Cytostatic
  106. Breast cancer is the leading cause of death in women between the ages of 40 and 55
  107. Paclitaxel
  108. Co-survivor
  109. Cyclophosphamide
  110. Ki-67 Rate
  111. AC Chemotherapy
  112. Capecitabine
  113. Checkpoint Inhibitor
  114. mTOR Inhibitors
  115. Flow Cytometry
  116. Apoptosis